Differences in the Clinical Outcome of Osteomyelitis by Treating Specialty: Orthopedics or Infectology
Open Access
- 17 December 2015
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (12), e0144736
- https://doi.org/10.1371/journal.pone.0144736
Abstract
Osteomyelitis is a heterogeneous infection with regard to etiology and treatment, and currently no single management protocol exists. Management of the condition is typically an interdisciplinary approach between orthopedics and infectious disease; however, the orthopedist is often the person who manages treatment. The aim of the study was to determine differences in the outcome of osteomyelitis according to its treating specialty and to identify factors associated with the recurrence of the disease. An ambispective cohort study of 129 patients with osteomyelitis was conducted and the proportions for qualitative variables and central tendency and dispersion measures for quantitative variables were calculated; the latter were tested for normality using the Shapiro-Wilk test. A bivariate analysis was conducted with measures of association based on the chi square test and crude relative risk. A logistic regression model was applied and statistical significance was set at p < 0.05, including the model of relevant clinical variables that fit the Hosmer-Lemeshow test. We found that 70% of patients were treated either by orthopedics or infectious disease. Patients who were treated by an orthopedist alone presented a greater risk of relapse or reinfection (RR = 4.6; 95% CI 2.3;8.9). Risk factors of osteomyelitis recurrence as determined in the regression model included the following: age of 57 years or older (RR = 1.3; 95% 0.3;5.2), long bones (RR = 1.9; 95% CI 0.5;7.1), fracture (RR = 5.0; 95% CI 0.4;51.4), monotherapy (RR = 3.0; 95% CI 0.6;14.5), receiving less than 4 weeks of antibiotics (RR = 1.5; 95% CI 0.2;10.1), inadequate treatment (RR = 3.1; 95% CI 0.4;20.1), and receiving orthopedics treatment (RR = 5.5; 95% CI 1.6;18.2). Most patients evaluated jointly by orthopedics and infectious disease received adequate treatment for osteomyelitis and had fewer relapses.This publication has 26 references indexed in Scilit:
- A Retrospective Comparison of Ceftriaxone Versus Oxacillin for Osteoarticular Infections Due to Methicillin-Susceptible Staphylococcus aureusClinical Infectious Diseases, 2011
- The Value of Infectious Diseases Consultation in Staphylococcus aureus BacteremiaThe American Journal of Medicine, 2010
- Mortality of S. aureus bacteremia and infectious diseases specialist consultation – A study of 521 patients in GermanyJournal of Infection, 2009
- Activity and impact on antibiotic use and costs of a dedicated infectious diseases consultant on a septic orthopaedic unitJournal of Infection, 2009
- Impact of Routine Infectious Diseases Service Consultation on the Evaluation, Management, and Outcomes ofStaphylococcus aureusBacteremiaClinical Infectious Diseases, 2008
- Improved Clinical Outcome of Patients With Candida Bloodstream Infections Through Direct Consultation by Infectious Diseases Physicians in a Japanese University HospitalInfection Control & Hospital Epidemiology, 2006
- Vertebral Osteomyelitis: Long‐Term Outcome for 253 Patients from 7 Cleveland‐Area HospitalsClinical Infectious Diseases, 2002
- Osteomyelitis in Grade II and III Open Tibia Fractures with Late DebridementJournal of Orthopaedic Trauma, 1995
- Evaluation of New Anti-Infective Drugs for the Treatment of Osteomyelitis in AdultsClinical Infectious Diseases, 1992
- Chronic Osteomyelitis Caused by Staphylococcus aureus: Controlled Clinical Trial of Nafcillin Therapy and Nafcillin-Rifampin TherapySouthern Medical Journal, 1986